Previous Article | Next Article ![]()
J Virol, January 1998, p. 811-816, Vol. 72, No. 1
Biochemistry Department,
Received 7 July 1997/Accepted 28 September 1997
The use of human immunodeficiency virus vectors for gene therapy is
hampered by concern over their safety. This concern might be
ameliorated, in part, if the viral accessory genes and proteins could
be eliminated from the vector genomes and particles. Here we describe a
minimal vector system that is capable of transducing nondividing cells
and which does not contain tat, vif,
vpr, vpu, and nef.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Minimal Requirement for a Lentivirus Vector Based
on Human Immunodeficiency Virus Type 1
*
Corresponding author. Mailing address: Biochemistry
Department, Oxford University, South Parks Rd., Oxford OX1 3QU, United Kingdom. Phone: 44-1865-275249. Fax: 44-1865-275259. E-mail:
akingsmn{at}bioch.ox.ac.uk.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|